COVID-19 Vaccination: 300,000 people have received at least one dose in Cameroon

COVID-19 Vaccination: 300,000 people have received at least one dose

For Dr. Manaouda Malachie, vaccination would be a shield against a 3rd wave. The press conference given on July 15, 2021 by the Minister of Public Health, marks the end of the 3rd round of consultations on the evaluation of the government’s response to COVID-19, which began last Monday with the Covid-19 vaccination campaign.

If the purpose of this press conference was to inform the public about the resolutions of the consultations with the actors of the Covid19 response team, the Ministerf also presented the new Covid-19 response strategy. The objective is to stop an eventual third wave, and to remove the misunderstandings which persist on the sensitive questions of the vaccination and its corollaries.

This meeting with the press also provided an opportunity to shed light on the role of pharmacopoeia in the treatment of COVID-19 in Cameroon through the approval of five local products as adjuvants.

In view of the magnitude of the second wave of contamination that occurred between December 2020 and March 2021 and the presence of the Delta variant reported in neighboring countries, the Cameroonian government, concerned about the well-being of its people, is committed to protecting its citizens.

Covid-19 Vaccination started on April 12, 2021 and the intensive campaign that runs until July 16 is in line with this objective. To date, 300,000 people have already received at least one dose of the two available vaccines (astra-zeneca and Sinopharm). Noting that the objectives expected at the time of the launch of this campaign have been reached, Minister Malachie MANAOUDA invited the public not to be diverted by the scientific evidence of social networks which only serve to lengthen the list of vaccine skeptics and vaccine hesitants.

Even if it remains voluntary, the Covid-19 vaccination still involves the responsibility of all in achieving the collective immunity sought, said the head of health. By establishing the difference between adjuvants (which accompany the main treatment) and the treatment (protocol put in place), the Minister of Health reassured that the traditional pharmacopoeia is in no way harmed in favor of exogenous solutions, but it remains wise to move forward with caution. The step taken with the recent registration of five adjuvant products is encouraging and shows the Government’s willingness to find local solutions to this fight.

But while waiting for an endogenous treatment, it is important to protect oneself from this malicious disease and to limit the damage which brings the country’s counter to date to 81871 positive cases, 80303 cured, and 1332 deaths. Beyond getting vaccinated, the Minister prescribed the scrupulous respect of the barrier measures enacted and still in force.

On the other hand, the Minister was keen to make a positive assessment of COVID 19 on the health system.

By the end of 2021, each region will be equipped with an oxygen production plant, as is the case for the COVID-19 Annex No. 2 patient care center at the Yaoundé Central Hospital. Furthermore, in addition to the Regional Hospital Centers which are being finalized and which all already have the latest generation scanners, all regional hospitals will also be equipped with scanners before the end of this year.

But already, all the health facilities of (1st, 2nd and 3rd) category have been supplied with oxygen therapy equipment, oxygen concentrators and microsity aspirators assigned to district hospitals and medical centers. These are some of the major achievements made in the framework of the response and which allow us to make a great leap forward in raising the technical level of health facilities, but also and above all to envisage a qualitative care of patients.

Leave a Comment